← All investors
About
4BIO Capital is a London venture firm founded in 2014 that invests exclusively in advanced therapies, including gene therapy, cell therapy, RNA-based therapy and microbiome treatments. It backs early-stage companies through company creation and Series A financings, with continued support across later rounds. Recent investments include Trogenix, Actithera and March Biosciences.
Industries
Biotech
Stage focus
SeedSeries A
Geography
EuropeUS
Raising from 4BIO Capital?
I've worked with founders across the industrial stack. If 4BIO Capital is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan